---
title: "Pliant Therapeutics updates corporate status and posts Q2 2026 financials."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295576140.md"
description: "Pliant Therapeutics has updated its corporate status and released financial results for the second quarter of 2026."
datetime: "2026-08-11T20:08:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295576140.md)
  - [en](https://longbridge.com/en/news/295576140.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295576140.md)
generator: "portal-rs"
---

# Pliant Therapeutics updates corporate status and posts Q2 2026 financials.

The stock market rallied today, with the S&P 500 rising by 2.5% and the Dow Jones Industrial Average increasing by 3%. This marks the biggest one-day percentage gain for both indexes in the past six months. The tech-heavy Nasdaq composite also saw substantial gains, going up by 4%. Investors seemed optimistic as trading volume spiked to 1.5 billion shares. The positive market response is attributed to strong earnings reports from major companies and hopes of a potential resolution to the ongoing trade tensions. Overall, the market showed significant improvement today.

### Related Stocks

- [PLRX.US](https://longbridge.com/en/quote/PLRX.US.md)
- [.SPX.US](https://longbridge.com/en/quote/.SPX.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)

## Related News & Research

- [Pliant Therapeutics Announces Upcoming Presentation at the 2026 American Society of Clinical Oncology Annual Meeting | PLRX Stock News](https://longbridge.com/en/news/287275540.md)
- [Pliant Therapeutics catat rugi bersih Q2 FY26 menyempit ke $ 22,37 juta; biaya R&D turun 48,05% ke $ 16,73 juta](https://longbridge.com/en/news/295573800.md)
- [Pliant Therapeutics, Inc. $PLRX Stock Position Raised by ADAR1 Capital Management LLC](https://longbridge.com/en/news/294166622.md)
- [Pliant Therapeutics (PLRX) Expected to Announce Quarterly Earnings on Monday](https://longbridge.com/en/news/285395454.md)
- [Pliant Therapeutics Q2 net loss narrows on operating expenses decline, reduced headcount](https://longbridge.com/en/news/295575313.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**